For TriloTalk episode 38, Lisa Chamberlain James, Senior Partner at Trilogy, and Sudipta Chakraborty, Head of Literacy & Plain Language Center of Excellence at Biogen, talk about how to use AI in the creation of lay summaries of clinical trial results. Scalability, change management, prompting, biases, realistic attitudes, and human involvement are all touched on so listen up!
All content for TriloTalk is the property of Trilogy Writing & Consulting and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
For TriloTalk episode 38, Lisa Chamberlain James, Senior Partner at Trilogy, and Sudipta Chakraborty, Head of Literacy & Plain Language Center of Excellence at Biogen, talk about how to use AI in the creation of lay summaries of clinical trial results. Scalability, change management, prompting, biases, realistic attitudes, and human involvement are all touched on so listen up!
Episode 24: Navigating the Global Transparency Landscape
TriloTalk
30 minutes
1 year ago
Episode 24: Navigating the Global Transparency Landscape
Welcome to Trilotalk Episode 24! In this episode, Douglas and Nidhi will take you through an overview of the recently introduced EU-CTR (Clinical Trial Regulation) - a hot topic in our industry these days! As medical writers, we need to be aware of not only what the EU-CTR is but also how it impacts the documents we often write. Join us to find out more about it! We will talk about what the EU-CTR is, the pros and cons of the new process, how a CTA in the EU is structured, and touch upon asso...
TriloTalk
For TriloTalk episode 38, Lisa Chamberlain James, Senior Partner at Trilogy, and Sudipta Chakraborty, Head of Literacy & Plain Language Center of Excellence at Biogen, talk about how to use AI in the creation of lay summaries of clinical trial results. Scalability, change management, prompting, biases, realistic attitudes, and human involvement are all touched on so listen up!
